Investors in Abbott Laboratories (Symbol: ABT) saw new options begin trading today, for the August 2026 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is ...
Abbott Laboratories (ABT) just picked up fresh FDA clearance and a CE Mark for its Amplatzer Piccolo Delivery System, a pediatric heart device upgrade that could quietly strengthen both its structural ...
Over the past 2 or 3 years, I've watched several businesses see slowdowns due to higher for longer interest rates. And with tariff implementations, this has become more evident, particularly from ...
Abbott Laboratories recently received U.S. FDA clearance and CE Mark for its Amplatzer Piccolo Delivery System, enabling more precise, minimally invasive closure of patent ductus arteriosus in ...
So I bought a Samsung very expensive refrigerator with a family hub and also paid for the extended warranty. Well it's been a month and a half since I have been out of a refrigerator! ABT sent a tech ...
Abbott Laboratories is a global healthcare company with a broad portfolio of products across various segments, including pharmaceuticals, diagnostics, nutritional products, and medical devices.
Parnassus Investments, an investment management firm, released its “Parnassus Value Equity Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. The fund focuses on ...
Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...
Neil Abt is senior editor of trucknews.com. He is a veteran journalist with 30 years of experience in reporting and public relations. Neil began his career covering sports for The Washington Post, ...
Abbott Laboratories (ABT), the global healthcare titan, announced on Dec. 22 that the U.S. Food and Drug Administration (FDA) has approved its Volt™ PFA System for treating atrial fibrillation (AFib).
Morningstar analysts do not currently cover ABT, but with our powerful screener, you can find stocks in the same sector,industry, or style and filter on our unbiased ratings and valuation metrics.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results